Anzeige
Mehr »
Mittwoch, 02.09.2026 - Börsentäglich über 12.000 News
Crypto.com-Deal ist fix! 22-Mio.-Firma sichert sich Zugang zu Billionen-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41YUS | ISIN: VGG3142E1473 | Ticker-Symbol:
NASDAQ
01.09.26 | 22:00
13,810 US-Dollar
0,00 % 0,000
Branche
Software
Aktienmarkt
ASIEN
1-Jahres-Chart
EUDA HEALTH HOLDINGS LIMITED Chart 1 Jahr
5-Tage-Chart
EUDA HEALTH HOLDINGS LIMITED 5-Tage-Chart

Aktuelle News zur EUDA HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
26.08.EUDA Health Holdings Ltd - 6-K, Report of foreign issuer2
26.08.EUDA Health Holdings Ltd: EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore3
30.07.EUDA Health Holdings Ltd: EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products325SINGAPORE, July 30, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services...
► Artikel lesen
28.07.EUDA Health Holdings Ltd - 6-K, Report of foreign issuer1
28.07.EUDA Health signs MOU for stem cell cancer therapy development5
28.07.EUDA Health Holdings Ltd: EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies602SINGAPORE, July 28, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services...
► Artikel lesen
EUDA HEALTH Aktie jetzt für 0€ handeln
10.06.EUDA Health Holdings Ltd - 6-K, Report of foreign issuer1
01.06.EUDA Health regains Nasdaq compliance after meeting minimum market value standards2
01.06.EUDA Health Holdings Ltd - 6-K, Report of foreign issuer1
01.06.EUDA Health expands product line with new stem cell mask2
01.06.EUDA Health regains Nasdaq listing compliance1
01.06.EUDA Health Holdings Ltd: EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask202SINGAPORE, June 01, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) ("EUDA" or the "Company"), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore...
► Artikel lesen
01.06.EUDA Health Holdings Ltd: EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency176Singapore, June 01, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited ("EUDA" and the "Company"), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia...
► Artikel lesen
28.04.EUDA Health Holdings Ltd - 20-F, Annual and transition report of foreign private issuers2
28.04.EUDA Health Holdings Ltd: EUDA Highlights Shenzhen Inno's Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development1
27.04.EUDA Health Holdings Ltd - 6-K, Report of foreign issuer-
27.04.EUDA Health: NASDAQ droht mit Delisting wegen zu geringer Marktkapitalisierung1
27.04.EUDA Health receives Nasdaq delisting warning over market value1
27.04.EUDA Health Holdings Ltd: EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities478Singapore, April 27, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited ("EUDA" and the "Company") received a written notice (the "MVLS Notice") from Listing Qualifications Department of The Nasdaq...
► Artikel lesen
19.03.EUDA Health Holdings Ltd - 6-K, Report of foreign issuer1
Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1